ChengDa Pharmaceuticals Co., Ltd.

¥23.59As of Sun 8 Nov 2026, 12:00 UTC
SZSE:301201Healthcare
Country China
PE (Fwd) •••
TSR 5Y CAGR (10.57%)
Div yield 0.85%
ROE (1.97%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.04)
PE TTM —
TSR TTM (27.69%)
Mkt cap ¥3.573B
ROIC (3.32%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥26
9.15%
13.85%
Hold 8|6|11|8|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.21
0.22
0.22
0.24
(0.64%)
6.20%
6.23%
9.18%
Revenue¥M
386.0
381.7
401.6
403.2
10.72%
3.38%
8.52%
7.93%
Peers (US$535.6M)
Cap (US$)
PE
537.6M
166.6x
537.1M
181.3x
534.0M
18.71x
Capital
TTM
5Y
10Y
Leveragex
2.100
0.499
0.401
EBIT/Intx
2.802
0.689
0.702
Own earn%
2.45
(18.76)
(19.99)
Sh yield%
31.47
29.35
28.90
Owners
Insiders/Inst%
0.39
35.03
Short interest%
4.50
SBC / revenue%
2.14
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
16–34
$1 testx
—
Incr. ROIC%
8